At the IGTP TODAY
The Escoles Sentinella project, coordinated by the CEEISCAT Group at IGTP, presented the main results of its fifth and final academic year. This initiative has shown that the network is viable and generates relevant scientific evidence on school health through collaboration between schools, researchers and public institutions.
IGTP has launched the European project TB-SPECTRUM, funded under the Horizon Europe programme through the MSCA Staff Exchanges scheme and coordinated by IGTP. A kick-off meeting held online brought together researchers, clinicians, and representatives from academic and non-academic institutions across Europe, Africa, and the United States, alongside members of the project's External Scientific and Ethics Advisory Boards.
Nearly one hundred professionals from the Innomed Program took part in this visit, an opportunity to gain first-hand insight into AstraZeneca’s scientific activity and explore new opportunities for collaboration.
A preclinical study led by IGTP, in collaboration with the Institut de Myologie and the IR Sant Pau, has analysed the role of the protein HDAC11 in Duchenne muscular dystrophy and its potential as a therapeutic target. The results of the study have been published in the journal Life Sciences.
The 8th Can Ruti Women for Equity in Science Symposium was held at IGTP as part of the International Day of Women and Girls in Science, observed annually on 11 February.
A multidisciplinary work led by IGTP researchers has analysed the relationship between climatic conditions, the presence of Legionella in water systems and cases of Legionnaires' disease in Catalonia, revealing a link between these different factors.
A recent study has carried out a systematic review of the scientific literature on omics data generated in pituitary tumours, with the aim of organising, cataloguing and facilitating the reuse of publicly available resources for future research projects.
The 2025 call for grants has funded 15 projects. One of them, led by the Fundació Lluita contra les Infeccions and involving the participation of IGTP, is called SuperCAP and focuses on improving the quality of life of people affected by long COVID.
A study led by researchers from the Resistance, Chemotherapy and Predictive Biomarkers group at the IGTP, published in Clinical and Translational Medicine, provides new evidence on how to improve the efficacy of one of the most widely used chemotherapy combinations in clinical practice for the treatment of colorectal cancer: 5-fluorouracil and irinotecan (FUIRI).
We look back at the year's most significant news stories, showcasing the dedication and collaboration that define IGTP.
